Stay updated with breaking news from Molecular Targeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Chung Lab at USC has developed a nanoparticle that attaches to immune cells, allowing it to target lymph nodes—a vital indicator of cancer metastasis—and enhance MRI detection, potentially revolutionizing cancer screenings by improving early detection of metastasis without invasive biopsies.
Rigging of the Cyclone® 30 XP in Poland completed with a further two sites in Germany and France already operational Louvain-la-Neuve, Belgium, December 12, 2023 – IBA ...
Rigging of the Cyclone 30XP in Poland completed with a further two sites in Germany and France already operational
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...
RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 -- Perspective Therapeutics, Inc. , a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents... | February 16, 2023